BioGeneration Ventures
BioGeneration Ventures

BioGeneration Ventures

DR39Ahrefs DR: 39/100. Below median. Measured by Ahrefs. Median 44.

Early-stage venture capital firm investing in innovative European life sciences companies with high unmet medical needs.

Website
2006VC4 portfolio$440.0M AUMNaarden, Netherlands

About

BioGeneration Ventures (BGV) is a venture capital firm specializing in seed and early-stage investments for innovative European life sciences companies, including biotech, medtech, and diagnostics. BGV acts as a lead investor, partnering with scientists and entrepreneurs to build new companies around disruptive solutions for high unmet medical needs. The firm focuses on translating academic scientific research into novel therapeutics and healthcare innovations.

Key facts

At-a-glance profile data

Website
biogenerationventures.com
Type
VC
Headquarters
Naarden, Netherlands
Funds raised
$440M
Portfolio companies
4
Stages
Pre-Seed
Seed
Series A
Cheque size
$2M to $2M
Sector focus
Biotechnology
Life Sciences
Healthcare
Drug Discovery
Medical Devices

Recent investments

Recent funding rounds BioGeneration Ventures took part in
DateCompanyRoundAmount
1 Aug 2026MironidSeries B$46M
28 May 2024MabylonSeries A$34M
1 May 2024MabylonUndisclosed round$2M
2 Nov 2021DUNAD TherapeuticsSeries A$24M
Add first review

Frequently asked

What companies has BioGeneration Ventures invested in?

BioGeneration Ventures has invested in Mironid, Mabylon, DUNAD Therapeutics, Agomab Therapeutics NV.